Does BEVACIZUMAB Cause Intestinal obstruction? 686 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 686 reports of Intestinal obstruction have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.9% of all adverse event reports for BEVACIZUMAB.
686
Reports of Intestinal obstruction with BEVACIZUMAB
0.9%
of all BEVACIZUMAB reports
147
Deaths
320
Hospitalizations
How Dangerous Is Intestinal obstruction From BEVACIZUMAB?
Of the 686 reports, 147 (21.4%) resulted in death, 320 (46.6%) required hospitalization, and 32 (4.7%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 686 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
VEDOLIZUMAB (1,263)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
RISANKIZUMAB-RZAA (853)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
INFLIXIMAB-DYYB (409)
Which BEVACIZUMAB Alternatives Have Lower Intestinal obstruction Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ